Image: Computer Simulation of SARS-CoV-2. Reprinted with kind permission of Janet Iwasa of http://animationlab.utah.edu/cova Update September 2024 COVID-19 Treatment Strategies As of 2023, a few small-molecule antiviral drugs (nirmatrelvir-ritonavir, remdesivir, and molnupiravir) and 11 monoclonal antibodies have been marketed for the treatment of COVID-19, mostly requiring administration within 10 days of symptom onset. Hospitalized patients with […]
Posted in Featured, Pharmacoepidemiology and Medical Device Safety 
Tags: AHCC, Calcifediol study, CASIRIVIMAB, Coronavirus, COVID-19, IMDEVIMAB, Interferon, Melatonin, SHADE study, Vitamin D 
Comments Off on COVID-19 Treatment Strategies: September 2024 update
Risk Management Consulting (RMC), a health services research firm, offers Research, Safety, and Epidemiology services with experience in the healthcare consulting and biopharmaceutical industries. RMC provides the health care system, biopharmaceutical industry, academia, and the Federal Government with “real-world” data to improve the quality, safety, and affordability of healthcare. RMC’s projects range from retrospective to […]
Posted in Featured, Pharmacoepidemiology and Medical Device Safety Tags: comparative effectiveness research, drug, health outcomes, large-scale studies, medical device safety surveillance, pharmacoeconomics, pharmacoepidemiology, prospective studies, retrospective studies, risk management, vaccine Comments Off on Combining Research, Safety, and Epidemiology| S | M | T | W | T | F | S |
|---|---|---|---|---|---|---|
| 1 | 2 | |||||
| 3 | 4 | 5 | 6 | 7 | 8 | 9 |
| 10 | 11 | 12 | 13 | 14 | 15 | 16 |
| 17 | 18 | 19 | 20 | 21 | 22 | 23 |
| 24 | 25 | 26 | 27 | 28 | 29 | 30 |
